Mindfulness Training for Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how stress-reduction classes can enhance brain function and alleviate symptoms in adults with Autism Spectrum Disorder (ASD). Participants will join one of two groups: one group will learn Mindfulness-Based Stress Reduction techniques, including mindfulness practices and gentle stretching, while the other will focus on relaxation and social support. Researchers will use brain scans and self-reports to assess changes in brain function related to improved emotional awareness and well-being. Adults with an ASD diagnosis who are attending college and can commit to most of the weekly classes may be suitable candidates. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research on stress reduction and ASD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both mindfulness-based stress reduction (MBSR) and relaxation techniques are generally safe for autistic adults. Studies have found that MBSR is a practical and well-received method for autistic adults in outpatient settings, often leading to a better quality of life and fewer autism symptoms without major side effects.
For the Relaxation Group, many people with autism have used mind-body therapies, including relaxation techniques. These methods help improve self-control and reduce stress-related issues. No strong evidence indicates major safety concerns with these practices.
Previous studies have shown that both treatments are well-tolerated, suggesting they are safe options for individuals with autism who want to manage stress.12345Why are researchers excited about this trial?
Researchers are excited about using mindfulness training for autism because it offers a non-drug approach to managing stress and improving well-being. Unlike medications that aim to address symptoms directly, mindfulness-based stress reduction uses techniques like meditation and focused breathing to help individuals with autism manage stress and anxiety. This approach is appealing because it empowers participants with skills they can use in daily life, potentially leading to lasting benefits without the side effects associated with medication. Additionally, the relaxation group provides a supportive environment to practice stress-relief techniques, which can enhance coping strategies and improve overall quality of life for those with autism.
What evidence suggests that this trial's treatments could be effective for autism?
Research has shown that Mindfulness-Based Stress Reduction (MBSR), one of the treatments in this trial, can help adults with autism spectrum disorder (ASD). Studies have found that MBSR lowers anxiety and depression, common in people with ASD. Participants often become more aware of their thoughts and feelings, improving mindfulness awareness. Meanwhile, the Relaxation Group, another treatment arm in this trial, uses relaxation techniques reported to help people with ASD feel calmer and manage emotions better. Both methods in this trial aim to reduce stress and improve overall well-being in individuals with ASD.26789
Who Is on the Research Team?
Brittany B Braden, PhD
Principal Investigator
Assistant Professor; Autism and Brain Aging Laboratory Director
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18-89 with Autism Spectrum Disorder (ASD), especially those in college. Participants must be able to attend most of the weekly classes and have an ASD diagnosis confirmed by standard assessments. Excluded are individuals with IQ <70, major medical conditions, seizure history, head trauma, claustrophobia or metal implants that affect MRI safety, and pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend stress reduction classes once a week for 8 weeks, involving either Mindfulness Based Stress Reduction or relaxation techniques with social support
Follow-up
Participants are monitored for changes in brain functioning and symptom improvements through MRI, EEG, and self-report data
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness Based Stress Reduction
- Relaxation Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
Banner Alzheimer's Institute
Collaborator
Southwest Autism Research and Resource Center (SARRC)
Collaborator